FDA
approval
· 2025-04-10
FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc., representing an approved …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BENICAR HCT (OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE)